REQUEST A DEMO
Total
USD $0.00
Search more companies

Era Pharmaceuticals Private Limited (India)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Era Pharmaceuticals Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Era Pharmaceuticals Private Limited is an unlisted company, incorporated on 22/04/2004. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U51397MH2004PTC145860 and registration number is 145860. The company is a trade company, it is engaged in wholesale trading.

Legal Address
910/ B, Samartha Aishwarya, Lokhandwala Complex Andheri (West)
Mumbai; Maharashtra; Postal Code: 400053

Contact Details: Purchase the Era Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Era Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Era Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Era Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
April 22, 2004
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Era Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
11.63%
Total operating revenue
12%
Operating profit (EBIT)
397.83%
EBITDA
358.63%
Net Profit (Loss) for the Period
503.31%
Total assets
9.77%
Total equity
22.31%
Operating Profit Margin (ROS)
4.39%
Net Profit Margin
3.5%
Return on Equity (ROE)
14.54%
Debt to Equity Ratio
-11.88%
Quick Ratio
0.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?